These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18622917)

  • 21. Population prevalence of first- and second-degree family history of breast and ovarian cancer.
    Moghimi-Dehkordi B; Safaee A; Vahedi M; Pourhoseingholi MA; Pourhoseingholi A; Zali MR
    East Afr J Public Health; 2011 Dec; 8(4):275-7. PubMed ID: 23120936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
    DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
    Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pros and cons of genetic testing for breast and ovarian cancer risk.
    Frank TS; Braverman AM
    Int J Fertil Womens Med; 1999; 44(3):139-45. PubMed ID: 10435912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines.
    Beckmann MW; Schnürch HG; Bodden-Heidrich R; Mosny DS; Crombach G; Nitz U; Achnoula M; Bender HG
    Eur J Cancer Prev; 1996 Dec; 5(6):468-75. PubMed ID: 9061278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The need for oncogenetic counselling. Ten years' experience of a regional oncogenetic clinic.
    Henriksson K; Olsson H; Kristoffersson U
    Acta Oncol; 2004; 43(7):637-49. PubMed ID: 15545184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial breast and ovarian cancers.
    Arai M; Utsunomiya J; Miki Y
    Int J Clin Oncol; 2004 Aug; 9(4):270-82. PubMed ID: 15375703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Indirect' BRCA1/2 testing: a useful approach in hereditary breast and ovarian cancer families without a living affected relative.
    Cruger DG; Kruse TA; Gerdes AM
    Clin Genet; 2005 Sep; 68(3):228-33. PubMed ID: 16098011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
    Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
    Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inherited breast and ovarian cancers].
    Gerdes AM; Ejlertsen B
    Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer.
    Contegiacomo A; Pensabene M; Capuano I; Tauchmanova L; Federico M; Turchetti D; Cortesi L; Marchetti P; Ricevuto E; Cianci G; Venuta S; Barbieri V; Silingardi V;
    Ann Oncol; 2004 May; 15(5):726-32. PubMed ID: 15111339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial breast cancer.
    Steel CM; Cohen BB; Porter DE
    Semin Cancer Biol; 1992 Jun; 3(3):141-50. PubMed ID: 1511156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ascertainment of familial ovarian cancer in the Aberdeen Genetic Clinic.
    Gregory H; Schofield A; de Silva D; Semper J; Milner B; Allan L; Haites N
    J Med Genet; 1996 Mar; 33(3):187-92. PubMed ID: 8728689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proband family uptake of familial-genetic counselling.
    Hagoel L; Dishon S; Almog R; Silman Z; Bisland-Becktell S; Rennert G
    Psychooncology; 2000; 9(6):522-7. PubMed ID: 11180587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial effects of prostate and other cancers on lifetime breast cancer risk.
    Anderson DE; Badzioch MD
    Breast Cancer Res Treat; 1993 Nov; 28(2):107-13. PubMed ID: 8173063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic counselling for those with a family history of breast or ovarian cancer--current practice and ethical issues.
    Richards MP
    Acta Oncol; 1999; 38(5):559-65. PubMed ID: 10427943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The multidisciplinary management of a family with epithelial ovarian cancer.
    Cruickshank DJ; Haites N; Anderson S; Matheson H; Hall MH; Milner B; Ah-See A; Gunn I; Eremin O; Gilbert F
    Br J Obstet Gynaecol; 1992 Mar; 99(3):226-31. PubMed ID: 1606122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Next-Generation Gene Sequencing: Looking Beyond Hereditary Breast and Ovarian Cancer.
    Estrada SS; LeGrazie B; McKamie T; Montgomery S
    Oncol Nurs Forum; 2015 Nov; 42(6):691-4. PubMed ID: 26488839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinic.
    Houlston RS; Lemoine L; McCarter E; Harrington S; MacDermot K; Hinton J; Berger L; Slack J
    J Med Genet; 1992 Oct; 29(10):691-4. PubMed ID: 1433227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients?
    Eerola H; Blomqvist C; Pukkala E; Pyrhönen S; Nevanlinna H
    Eur J Cancer; 2000 Jun; 36(9):1143-8. PubMed ID: 10854948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial breast cancer: report of a family pedigree.
    Armstrong AE; Davies JM
    Br J Cancer; 1978 Feb; 37(2):294-307. PubMed ID: 629864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.